The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $74.45

Today's change-0.04 -0.05%
Updated December 24 1:03 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $74.45

Today's change-0.04 -0.05%
Updated December 24 1:03 PM EST. Delayed by at least 15 minutes.

Baxter International Inc down slightly

Baxter International Inc closed down just (U.S.)$0.04 Wednesday to (U.S.)$74.45. Over the last five days, shares have gained 3.02% and are currently 3.70% off of the 52-week high. Shares have underperformed the S&P 500 by 5.75% during the last year.

Key company metrics

  • Open(U.S.) $74.23
  • Previous close(U.S.) $74.49
  • High(U.S.) $74.78
  • Low(U.S.) $74.09
  • Bid / Ask-- / --
  • YTD % change+7.05%
  • Volume855,799
  • Average volume (10-day)2,630,353
  • Average volume (1-month)2,415,730
  • Average volume (3-month)2,873,910
  • 52-week range(U.S.) $66.34 to (U.S.) $77.31
  • Beta0.71
  • Trailing P/E23.26×
  • P/E 1 year forward15.27×
  • Forward PEG2.47×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.79%
  • Trailing EPS(U.S.) $3.20
Updated December 24 1:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.55%

Based on its net profit margin of 10.55%, Baxter International Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,1974,2643,9514,368
Total other revenue--------
Total revenue4,1974,2643,9514,368
Gross profit2,0742,1161,9731,954
Total cost of revenue2,1232,1481,9782,414
Total operating expense3,6193,5483,2403,936
Selling / general / administrative921961903982
Research & development292292282261
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)28314777279
Other operating expenses, total--------
Operating income578716711432
Interest income (expense), net non-operating-36-47-48-49
Gain (loss) on sale of assets--------
Other--------
Income before tax586661709431
Income after tax447520556326
Income tax, total139141153105
Net income468520556326
Total adjustments to net income--------
Net income before extra. items447520556326
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items447520556326
Inc. avail. to common incl. extra. items468520556326
Diluted net income468520556329
Dilution adjustment------3
Diluted weighted average shares547548548546
Diluted EPS excluding extraordinary itemsvalue per share0.820.951.010.60
Dividends per sharevalue per share0.520.520.490.49
Diluted normalized EPSvalue per share1.211.161.120.99